Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T C Wu

Showing results (191-200 of 562) with videos related to

Pageof 57
Sort By:
Antibiotiki|February 19, 2014
[Effect of two antibiotics (23-21 and 1779) on experimental tumors]B HSU, M C LIU, T C WU, et al.
Journal of Immunology Research|January 14, 2022
Control of Tumors by Antigen-Specific CD8<sup>+</sup> T Cells through PDL1-Targeted Delivery of Antigenic PeptidePo-Hao Feng, Xiaoxu Wang, Louise Ferrall, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 28, 2009
Treatment with cyclooxygenase-2 inhibitors enables repeated administration of vaccinia virus for control of ovarian cancerChih-Long Chang, Barbara Ma, Xiaowu Pang, et al.
Zhonghua Yi Xue Za Zhi|December 15, 2021
[Comparison of alignment between computer assisted surgery and personal specific instrumentation in total knee arthroplasty]X G Wang, Y Li, Y Z He, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 28, 2012
Targeted coating with antigenic peptide renders tumor cells susceptible to CD8(+) T cell-mediated killingTae Heung Kang, Barbara Ma, Connie Wang, et al.
Human Gene Therapy|July 17, 2008
RNA interference-mediated in vivo silencing of fas ligand as a strategy for the enhancement of DNA vaccine potencyBruce Huang, Chih-Ping Mao, Shiwen Peng, et al.
Plos One|December 23, 2014
Cancer immunotherapy employing an innovative strategy to enhance CD4+ T cell help in the tumor microenvironmentLiwen Song, Ming-Chieh Yang, Jayne Knoff, et al.
Journal of Assisted Reproduction and Genetics|June 1, 1992
Successful management of predicted severe ovarian hyperstimulation syndrome with gonadotropin-releasing hormone agonistT C Wu, T J Gelety, M H Jih, et al.
Expert Opinion on Biological Therapy|August 27, 2005
Immunotherapy for gynaecological malignanciesGeorge Coukos, Jose R Conejo-Garcia, Richard B S Roden, et al.
Expert Review of Vaccines|April 6, 2007
Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cellsShaw-Wei D Tsen, Augustine H Paik, Chien-Fu Hung, et al.
Pageof 57

Showing results (191-200 of 562) with videos related to

Sort By:
Pageof 57
Antibiotiki|February 19, 2014
[Effect of two antibiotics (23-21 and 1779) on experimental tumors]B HSU, M C LIU, T C WU, et al.
Journal of Immunology Research|January 14, 2022
Control of Tumors by Antigen-Specific CD8<sup>+</sup> T Cells through PDL1-Targeted Delivery of Antigenic PeptidePo-Hao Feng, Xiaoxu Wang, Louise Ferrall, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 28, 2009
Treatment with cyclooxygenase-2 inhibitors enables repeated administration of vaccinia virus for control of ovarian cancerChih-Long Chang, Barbara Ma, Xiaowu Pang, et al.
Zhonghua Yi Xue Za Zhi|December 15, 2021
[Comparison of alignment between computer assisted surgery and personal specific instrumentation in total knee arthroplasty]X G Wang, Y Li, Y Z He, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 28, 2012
Targeted coating with antigenic peptide renders tumor cells susceptible to CD8(+) T cell-mediated killingTae Heung Kang, Barbara Ma, Connie Wang, et al.
Human Gene Therapy|July 17, 2008
RNA interference-mediated in vivo silencing of fas ligand as a strategy for the enhancement of DNA vaccine potencyBruce Huang, Chih-Ping Mao, Shiwen Peng, et al.
Plos One|December 23, 2014
Cancer immunotherapy employing an innovative strategy to enhance CD4+ T cell help in the tumor microenvironmentLiwen Song, Ming-Chieh Yang, Jayne Knoff, et al.
Journal of Assisted Reproduction and Genetics|June 1, 1992
Successful management of predicted severe ovarian hyperstimulation syndrome with gonadotropin-releasing hormone agonistT C Wu, T J Gelety, M H Jih, et al.
Expert Opinion on Biological Therapy|August 27, 2005
Immunotherapy for gynaecological malignanciesGeorge Coukos, Jose R Conejo-Garcia, Richard B S Roden, et al.
Expert Review of Vaccines|April 6, 2007
Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cellsShaw-Wei D Tsen, Augustine H Paik, Chien-Fu Hung, et al.
Pageof 57